Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Almqvist

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Haematology|September 1, 1991
Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemiaI P Palva, A Almqvist, E Elonen, et al.
European Journal of Haematology|August 1, 1993
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia GroupI P Palva, K Ala-Harja, A Almqvist, et al.
European Journal of Haematology|January 1, 1987
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
European Journal of Haematology|February 1, 1990
Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala Harja, et al.
European Journal of Haematology|October 1, 1989
Treatment of multiple myeloma in old patients. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Leukemia & Lymphoma|July 27, 2016
Effect of the Choice of Primary Chemotherapy on the Cumulative Length of Stay in Hospital for Multiple MyelomaI P Palva, P Ahrenberg, K Ala-Harja, et al.
Tribology Letters|July 29, 2025
The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of TopographyA Pradhan, M H Müser, N Miller, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Haematology|September 1, 1991
Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemiaI P Palva, A Almqvist, E Elonen, et al.
European Journal of Haematology|August 1, 1993
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia GroupI P Palva, K Ala-Harja, A Almqvist, et al.
European Journal of Haematology|January 1, 1987
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
European Journal of Haematology|February 1, 1990
Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala Harja, et al.
European Journal of Haematology|October 1, 1989
Treatment of multiple myeloma in old patients. Finnish Leukaemia GroupI P Palva, P Ahrenberg, K Ala-Harja, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Leukemia & Lymphoma|July 27, 2016
Effect of the Choice of Primary Chemotherapy on the Cumulative Length of Stay in Hospital for Multiple MyelomaI P Palva, P Ahrenberg, K Ala-Harja, et al.
Tribology Letters|July 29, 2025
The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of TopographyA Pradhan, M H Müser, N Miller, et al.
Pageof 2